Search | TVST | ARVO Journals

Showing 1 – 20 of 22

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2020

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

SANJEEB BHANDARI; Vuong Nguyen; Samantha Fraser-Bell; Hemal Mehta; Francesco Viola; Florian Baudin; Pierre-Henry Gabrielle; Catherine P Creuzot Garcher; Mark C Gillies; Daniel Barthelmes

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3289. doi:

Articles May 2020

A Mitochondrial Genome-Wide Association Study of Cataract in a Latino Population

PDF

Brendan Miller; Mina Torres; Xuejuan Jiang; Roberta McKean-Cowdin; Darryl Nousome; Su-Jeong Kim; Hemal H. Mehta; Kelvin Yen; Pinchas Cohen; Rohit Varma
TAGS: cataract, genome-wide association study, hispanics or latinos, mitochondria
Trans. Vis. Sci. Tech.. 2020; 9(6):25. doi: https://doi.org/10.1167/tvst.9.6.25

Includes: Supplemental Content

ARVO Annual Meeting Abstract July 2019

A randomised clinical trial of slow versus fast intravitreal injection of ranibizumab (Lucentis®) and its impact on intraocular pressure (the Speed IOP Study)

Samantha Fraser-Bell; Sophia Zagora; Hemal Mehta; Anna Campain; Hon Seng Wong; Yeung Aaron; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):79. doi:

ARVO Annual Meeting Abstract July 2019

Visual outcomes and optical coherence tomography features in young adults born extremely preterm: The EPICure@19 Study

Siva Balasubramanian; Saurabh Jain; Joanne Beckmann; Karntida Chanwimol; Marco Nassisi; Irena Tsui; Neil Marlow; Srinivas R Sadda; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4754. doi:

ARVO Annual Meeting Abstract July 2019

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

SANJEEB BHANDARI; Anne Catherine Biechl; Jennifer Joan Arnold; Stephanie Young; Samanta Fraser-Bell; Hemal Mehta; Mark C Gillies; Daniel Barthelmes; Vuong Nguyen

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):2602. doi:

ARVO Annual Meeting Abstract July 2019

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Sarah Ah-Moye; Pardis Zalmay; Magnus Theodorsson; Martin Lynn Harris; Riaz Asaria; Adrian Hunt; Daniel Barthelmes; Mark C Gillies; Vuong Nguyen; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2019; 60(9):4061. doi:

ARVO Annual Meeting Abstract July 2018

Real-world visual outcomes at 24 weeks in patients with diabetic macular edema receiving aflibercept intravitreal injections as per UK license.

Charles Hennings; Mira Deshmukh; Vuong Nguyen; Martin Harris; Riaz Asaria; Daniel Barthelmes; Mark C Gillies; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):3616. doi:

ARVO Annual Meeting Abstract July 2018

Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

Elisa Eleanor Cornish; Kelvin Yi Chong Teo; Mark C Gillies; Lyndell L Lim; Ian McAllister; Sutha Sanmugasundram; Vuong Nguyen; Sanjeewa Wickremasinghe; Hemal Mehta; Samantha Fraser-Bell

Invest. Ophthalmol. Vis. Sci.. 2018; 59(9):4847. doi:

ARVO Annual Meeting Abstract June 2017

The mitochondrial-derived peptide humanin improves mitochondrial bioenergetics after endoplasmic reticulum stress in human RPE cells

Hiroto Terasaki; Parameswaran G Sreekumar; Hemal H Mehta; Pinchas Cohen; David R Hinton; Ram Kannan

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):5361. doi:

ARVO Annual Meeting Abstract June 2017

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

Panagiotis Vasilopoulos; Andrew R Webster; Catherine A Egan; Hemal Mehta; Philip G Hykin

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):4639. doi:

ARVO Annual Meeting Abstract June 2017

Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license

Mehmet Ozturk; Martin Harris; Vuong Nguyen; Daniel Barthelmes; Mark C Gillies; Hemal Mehta

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):881. doi:

ARVO Annual Meeting Abstract June 2017

Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years – Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema

Hemal Mehta; Samantha Fraser-Bell; Vuong Nguyen; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2017; 58(8):1895. doi:

ARVO Annual Meeting Abstract September 2016

Humanin enhances mitochondrial biogenesis in RPE cells

Parameswaran G Sreekumar; Hiroto Terasaki; Christine Spee; Hemal H Mehta; Junxiang Wan; Kelvin Yen; Pinchas Cohen; Ram Kannan; David R Hinton

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):5016. doi:

ARVO Annual Meeting Abstract September 2016

Progression of Diabetic Retinopathy in the Bevordex study: a randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema

Lyndell L Lim; Dania Qatarneh; Lauren Hodgson; Hemal Mehta; Sanjeewa Wickremasinghe; Anna Campain; Mark C Gillies; Samantha Fraser-Bell

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):2106. doi:

ARVO Annual Meeting Abstract September 2016

Subretinal fluid in Macular telangiectasia type 2 without apparent choroidal neovascularization

Hemal Mehta; Simona Degli Esposti; Catherine A Egan; Mark C Gillies

Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):4443. doi:

Retinal Cell Biology March 2016

The Mitochondrial-Derived Peptide Humanin Protects RPE Cells From Oxidative Stress, Senescence, and Mitochondrial Dysfunction

PDF

Parameswaran G. Sreekumar; Keijiro Ishikawa; Chris Spee; Hemal H. Mehta; Junxiang Wan; Kelvin Yen; Pinchas Cohen; Ram Kannan; David R. Hinton
TAGS: aging, oxidative stress, mitochondria, peptides, elderly, retinal pigment cell
Invest. Ophthalmol. Vis. Sci.. 2016; 57(3):1238-1253. doi: https://doi.org/10.1167/iovs.15-17053

Includes: Supplemental Content

ARVO Annual Meeting Abstract June 2015

The cytoprotective peptide humanin protects RPE cells from oxidative stress by modulating mitochondrial bioenergetics and delayed RPE senescence

Parameswaran G Sreekumar; Keijiro Ishikawa; Christine Spee; Hemal H Mehta; Junxiang Wang; Kelvin Yen; Pinchas Cohen; Ram Kannan; David R Hinton

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):833. doi:

ARVO Annual Meeting Abstract June 2015

BEVORDEX - A multicentre randomized clinical trial of intravitreal dexamethasone versus intravitreal bevacizumab for persistent diabetic macular edema

Mark C Gillies; Lyndell L Lim; Anna E Campain; Hemal Mehta; Godfrey Quin; Samantha Fraser-Bell; Ian McAllister; Wedad Salem; Ji Li

Invest. Ophthalmol. Vis. Sci.. 2015; 56(7 ):3144. doi:

ARVO Annual Meeting Abstract April 2014

Using optical coherence tomography to distinguish intraretinal microvascular abnormalities from neovascular complexes in diabetic retinopathy

Hemal Mehta; Dawn A Sim; Pearse Andrew Keane; Javier Zarranz-Ventura; Marcus Fruttiger; Catherine A Egan; Adnan Tufail

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3425. doi:

ARVO Annual Meeting Abstract April 2014

Humanin protects RPE cells from oxidative stress induced cell death

Parameswaran G Sreekumar; Keijiro Ishikawa; Christine Spee; Hemal Mehta; Kelvin Yen; Pinchas Cohen; Ram Kannan; David R Hinton

Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3445. doi:

1 2

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Ranibizumab or Aflibercept for Diabetic Macular Edema: One-Year Comparison of Real-World Outcomes from Fight Retinal Blindness! Registry.

A Mitochondrial Genome-Wide Association Study of Cataract in a Latino Population

A randomised clinical trial of slow versus fast intravitreal injection of ranibizumab (Lucentis®) and its impact on intraocular pressure (the Speed IOP Study)

Visual outcomes and optical coherence tomography features in young adults born extremely preterm: The EPICure@19 Study

Changes in real world treatment patterns for diabetic macular edema and five year treatment outcomes: data from the Fight Retinal Blindness! Project

Real-world outcomes in patients with macular oedema secondary to central retinal vein occlusion receiving intravitreal anti-VEGF therapy in a UK public hospital setting

Real-world visual outcomes at 24 weeks in patients with diabetic macular edema receiving aflibercept intravitreal injections as per UK license.

Five year outcomes of the Bevordex Study (a multicenter randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone).

The mitochondrial-derived peptide humanin improves mitochondrial bioenergetics after endoplasmic reticulum stress in human RPE cells

Clinical, optical coherence tomography and fundus autofluorescence findings in atrophic maculopathy associated with pseudoxanthoma elasticum

Real-world visual outcomes in patients with neovascular age-related macular degeneration receiving aflibercept (Eylea) intravitreal injections at fixed intervals as per UK license

Short-term vision gains at 12 weeks correlate with long-term vision gains at 2 years – Results from the BEVORDEX randomized clinical trial of bevacizumab versus dexamethasone implants for diabetic macular edema

Humanin enhances mitochondrial biogenesis in RPE cells

Progression of Diabetic Retinopathy in the Bevordex study: a randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema

Subretinal fluid in Macular telangiectasia type 2 without apparent choroidal neovascularization

The Mitochondrial-Derived Peptide Humanin Protects RPE Cells From Oxidative Stress, Senescence, and Mitochondrial Dysfunction

The cytoprotective peptide humanin protects RPE cells from oxidative stress by modulating mitochondrial bioenergetics and delayed RPE senescence

BEVORDEX - A multicentre randomized clinical trial of intravitreal dexamethasone versus intravitreal bevacizumab for persistent diabetic macular edema

Using optical coherence tomography to distinguish intraretinal microvascular abnormalities from neovascular complexes in diabetic retinopathy

Humanin protects RPE cells from oxidative stress induced cell death

To View More...

You must be signed into an individual account to use this feature.